OS Therapies (OSTX) Q1 2026 Annual Earnings
OSTX·Reported May 18, 2026·Before market open
Diluted EPS came in at $-0.27 (-50.0% YoY), missed the $-0.17 consensus by $0.10.
Diluted EPS
$-0.27missed by $0.10
Consensus: $-0.17
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about OS Therapies's Q1 2026 earnings report.
OS Therapies (OSTX) reported Q1 2026 earnings on May 18, 2026 before market open.
OS Therapies reported diluted EPS of $-0.27 for Q1 2026.
EPS missed the consensus estimate of $-0.17 by $0.10.
Compared to the same quarter a year prior, diluted EPS declined 50.0% from $-0.18.
You can read the 10-K periodic report (0001213900-26-036629) directly on SEC EDGAR. The filing index links above go to sec.gov.